41-50 of 79 results
Allens advises Archer Capital on sale of Healthe Care
Allens has advised Archer Capital on its proposed divestment of private hospital business Healthe Care to China's Luye Medical Group. Healthe Care is Australia's third largest private hospital ...
Competition news
In Touch looks at what's been happening in Competition this month and what it means for your business ...
Spotlight: Cyber breach at Target
There's a joke in the cyber security industry that there are two types of companies: those that know they have been hacked, and those that haven't yet found out. In November 2013, Target Corporation in the US learned this the hard way when it was told by law enforcement agencies that it had been sub ...
Directors' duties and cyber resilience
The Target data breach brought the liability of boards and directors in relation to cyber resilience into focus. Target's shareholders brought litigation against all of its directors, the chief financial officer and the chief information officer due to what was perceived as recklessness and disregar ...
Incoming Notifiable Data Breaches Scheme
There is no current legal obligation under the Privacy Act to notify either the Privacy Commissioner or affected individuals where you suffer a data breach. However, mandatory data breach notification laws will take effect in Australia from 22 February 2018. ...
NSW to bolster cyber security
The NSW Government has recently announced a new $11.4 million investment to address emerging technology challenges including cyber security. ...
In the Know: Cyber vernacular
The Department of Prime Minister and Cabinet has recently considered an early draft of a document defining a new 'cyber lexicon' at a roundtable hosted by Alastair MacGibbon, Special Adviser to the Prime Minister on Cyber Security. The document, titled 'Words Matter: Australia's Cyber Security Lexic ...
High Court unanimously finds isolated genetic material not patentable
In the culmination of a hard-fought patent dispute the High Court of Australia has unanimously ruled that Myriad Genetics patent claims to isolated nucleic acid coding for the mutant or polymorphic BRCA1 polypeptide are not valid ...
Allens advises Clearskincare on $127.4m acquisition
Allens has advised the founders of Clearskincare on the sale of the brand's clinic and products businesses to Australian Pharmaceutical Industries (API) for $127.4 million. Under the deal, API will ...
Allens advises PEP on acquisition of LifeHealthcare
Allens has advised private equity fund manager Pacific Equity Partners (PEP) in relation to the acquisition of ASX-listed LifeHealthcare Group Limited (LifeHealthcare) by Pacific Health Supplies ...